Arctic Bioscience AS provided revenue guidance for the year 2022. For the year, the company expects a positive development in revenues during the second half of 2022, forecasting a 60% to 70 % year on year revenue growth in 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.9 NOK | 0.00% | -1.00% | -5.71% |
03-01 | Arctic Bioscience AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-01 | Transcript : Arctic Bioscience AS, Q4 2023 Earnings Call, Mar 01, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.71% | 23.75M | |
+43.03% | 750B | |
+34.11% | 606B | |
-6.42% | 356B | |
+18.72% | 326B | |
+6.41% | 286B | |
+18.08% | 246B | |
-3.44% | 213B | |
+11.35% | 213B | |
+1.95% | 167B |
- Stock Market
- Equities
- ABS Stock
- News Arctic Bioscience
- Arctic Bioscience as Provides Revenue Guidance for the Year 2022